Literature DB >> 22057166

[Role of three ELISA tests using promastigote homogenates of Leishmania braziliensis, L. amazonensis and L. guyanensis in the diagnosis of tegumentary leishmaniasis].

José F Gil1, Carlos L Hoyos, Rubén O Cimino, Alejandro J Krolewiecki, Inés López Quiroga, Silvana P Cajal, Marisa Juárez, María F García Bustos, María C Mora, Jorge D Marco, Julio R Nasser.   

Abstract

It is important to know whether the variability of species of Leishmania parasites circulating in a region affects the performance of the ELISA test for the diagnosis of leishmaniasis. Therefore, the aim of this study was to analyze the reactivity of the ELISA using homogenates of promastigotes of Leishmania (V.) braziliensis (ELISAb), Leishmania (L) amazonensis (ELISAa) and Leishmania (V.) guyanensis (ELISAg) against different sera groups. Samples from individuals with cutaneous leishmaniasis (n = 37), mucocutaneous leishmaniasis (n = 8), healthy controls (n = 52), persons infected with Trypanosoma cruzi (n = 11) and mixed infections (n = 14) were included in the study. We calculated sensitivities, specificities, cut offs, and predictive values for the three tests and compared them using ANOVA, kappa index, ROC curves comparison, and confidence intervals calculated by the bootstrap method. Significant differences were found when comparing the OD levels of sera from patients with cutaneous leishmaniasis against healthy controls, but there were no differences when comparing the different ELISAs. The sensitivities calculated for ELISAb and ELISAa were 84.6 and of 88.5% for ELISAg, while the value of specificity for the three tests was 96.2. The kappa index (0.87) and comparison of ROC curves showed similar performance for the three ELISAs (p = 0.225). The high reactivity obtained for these ELISAs in sera of patients with mucocutaneous leishmaniasis indicates this test as an important complement in the diagnosis of the disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057166

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN: 0025-7680            Impact factor:   0.653


  5 in total

1.  Restricted outbreak of American tegumentary leishmaniasis with high microfocal transmission.

Authors:  Alejandro J Krolewiecki; José F Gil; Marcelo Quipildor; Silvana P Cajal; Carlos Pravia; Marisa Juarez; Carlos Villalpando; Fabricio M Locatelli; Mariana Chanampa; Gabriela Castillo; María F Oreste; Carlos L Hoyos; Vanesa Negri; Julio R Nasser
Journal:  Am J Trop Med Hyg       Date:  2013-01-21       Impact factor: 2.345

2.  Polymorphism-specific PCR enhances the diagnostic performance of American tegumentary leishmaniasis and allows the rapid identification of Leishmania species from Argentina.

Authors:  Jorge D Marco; Paola A Barroso; Tatsuyuki Mimori; Fabricio M Locatelli; Ayako Tomatani; María C Mora; S Pamela Cajal; Julio R Nasser; Luis A Parada; Taketoshi Taniguchi; Masataka Korenaga; Miguel A Basombrío; Yoshihisa Hashiguchi
Journal:  BMC Infect Dis       Date:  2012-08-15       Impact factor: 3.090

3.  Cutaneous Leishmaniasis in dogs: is high seroprevalence indicative of a reservoir role?

Authors:  José E Calzada; Azael Saldaña; Kadir González; Chystrie Rigg; Vanessa Pineda; Ana María Santamaría; Indra Rodríguez; Nicole L Gottdenker; Marcia D Laurenti; Luis F Chaves
Journal:  Parasitology       Date:  2015-05-20       Impact factor: 3.234

4.  Epidemiology of American Tegumentary Leishmaniasis and Trypanosoma cruzi Infection in the Northwestern Argentina.

Authors:  Carlos L Hoyos; Silvana P Cajal; Marisa Juarez; Jorge D Marco; Anahí M Alberti D'Amato; Melina Cayo; Irma Torrejón; Rubén O Cimino; Patricio Diosque; Alejandro J Krolewiecki; Julio R Nasser; José F Gil
Journal:  Biomed Res Int       Date:  2016-09-29       Impact factor: 3.411

5.  Field validation of a Leishmania (Leishmania) mexicana exo-antigens ELISA for diagnosing tegumentary leishmaniasis in regions of Leishmania (Viannia) predominance.

Authors:  Killarney Ataide Soares; Ada Amália Ayala Urdapilleta; Gilcilene Maria dos Santos; Andréa Lisboa Carneiro; Ciro Martins Gomes; Ana Maria Roselino; Raimunda Nonata Ribeiro Sampaio
Journal:  Braz J Infect Dis       Date:  2015-05-15       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.